TCL Archive FDA Committee Okays High Dose Methotrexate, Mitxantrone In ANL; reverse Breast Cancer Vote December 11, 1987
TCL Archive Semantics: NIH to Drop “Alternative From Center’s Name; Integrative Better Describes Current Focus June 6, 2014
TCL Archive Dramatic responses to Iressa prompted further bench research. Results have limited clinical relevance, for now, but findings may explain failure of INTACT studies. April 30, 2004
